Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright
H.C. Wainwright maintains a Buy rating on Invivyd (IVVD) with a $10 price target after the FDA rejected its submission to expand Pemgarda’s ...
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...
Protagonist Therapeutics price target raised to $54 from $50 at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao raised the firm’s price target on Protagonist Therapeutics (PTGX) to $54 from $50 and keeps a Buy rating ...
Benitec Biopharma’s (BNTC) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent ...
Ardelyx’s (ARDX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to ...
manilatimes2h
Liberty Defense Selects Isotec Security Inc. for a Strategic Partnership and Increased Market Penetration for the High Security Vertical
Isotec Security Inc. to sell Liberty's next generation threat detection HEXWAVE system to the US Urban Security market.
Karyopharm Therapeutics Inc.: Karyopharm Announces 1-for-15 Reverse Stock Split
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies ...